RD Medicine

How To Present A Hematology-Oncology Case During A U.S. Clinical Experience

USMLE
RD Medicine - USMLE

RD Medicine - USMLE

NOVEMBER 20, 2026
How To Present A Hematology-Oncology Case During A U.S. Clinical Experience

A hematology-oncology presentation may include serial blood counts, pathology, cytogenetics, treatment history, imaging, and multiple complications.

The goal is not to reproduce the entire medical record. It is to identify the most important problem, demonstrate its severity, and explain what needs to happen next.

Begin With A Statement That Locates The Case

Include:

  • Age and relevant characteristics.
  • Main diagnosis or syndrome.
  • Disease or treatment phase.
  • Current problem.
  • Clinical stability.

For example:

“A 58-year-old patient with newly diagnosed acute myeloid leukemia, currently on day eight after induction chemotherapy, presents with fever and profound neutropenia but is hemodynamically stable.”

This sentence immediately explains who the patient is, where the patient is in the disease trajectory, and why the patient is being evaluated.

Define The Disease Status

Use precise terms:

  • Newly diagnosed.
  • Undergoing induction.
  • Receiving consolidation.
  • In remission.
  • Refractory.
  • Recurrent or relapsed.
  • Receiving palliative treatment.
  • Under surveillance.

Do not automatically use remission as a synonym for cure. Its meaning depends on the disease and the criteria used. In AML, remission assessment incorporates peripheral blood, bone marrow, and extramedullary findings.

Present The Treatment Timeline

Organize events clinically:

  1. When and how the diagnosis was established.
  2. Which treatment was initiated.
  3. The current treatment day or cycle.
  4. The response observed.
  5. The complications that occurred.
  6. The current decision.

For example:

“The diagnosis was confirmed through bone marrow biopsy and flow cytometry. The patient began induction eight days ago and subsequently developed pancytopenia, with a new fever this morning.”

Select The Relevant CBC Data

Do not read every number. Present the relevant trends:

  • Current hemoglobin and its trend.
  • Platelet count.
  • White blood cell count.
  • Absolute neutrophil count.
  • Presence of blasts.
  • Recent transfusion requirements.

For example:

“The absolute neutrophil count has declined to below 100 cells/µL, the platelet count is 18,000/µL, and hemoglobin remains stable after transfusion.”

Present Pathology And Molecular Data Hierarchically

Organize the results into four levels:

  1. Histologic or morphologic diagnosis.
  2. Immunophenotype.
  3. Cytogenetics.
  4. Relevant molecular alterations.

Include only findings that contribute to the diagnosis, prognosis, treatment selection, or monitoring.

For solid tumors, report:

  • Primary site.
  • Histologic type.
  • Grade.
  • Stage.
  • Relevant biomarkers.
  • Sites of metastatic disease.

Prioritize Emergencies

Before discussing cancer details, report whether there is:

  • Hemodynamic instability.
  • Febrile neutropenia.
  • Bleeding.
  • Leukostasis.
  • Tumor lysis syndrome.
  • Spinal cord compression.
  • Superior vena cava syndrome.
  • Hypercalcemia.
  • Sepsis.
  • A transfusion reaction.

A presentation may begin with the oncologic diagnosis, but it should quickly reach the most urgent complication.

Present The Response To Treatment

Report:

  • Symptom changes.
  • Disease reduction or progression.
  • Recovery or worsening of blood counts.
  • Imaging findings.
  • Bone marrow assessment.
  • Measurable residual disease when applicable.
  • Toxicities that alter treatment.

Avoid vague statements such as “the patient is doing better.”

Use:

“The patient is afebrile, remains hemodynamically stable, and the oxygen requirement has decreased.”

Organize The Assessment By Problem

For example:

  1. Febrile neutropenia after induction chemotherapy.
  2. Acute myeloid leukemia under treatment.
  3. Severe thrombocytopenia without active bleeding.
  4. Anemia related to disease and treatment.
  5. Risk of infectious complications.

This structure makes the presentation easier to follow.

End With A Clear Plan

The plan may include:

  • Cultures and infectious evaluation.
  • Antimicrobial therapy according to protocol.
  • Hemodynamic monitoring.
  • Transfusion support.
  • Electrolyte and kidney function monitoring.
  • Tumor lysis prevention or treatment.
  • Medication review.
  • Treatment response assessment.
  • Consultation with other services.
  • Level of care and disposition.

End with a specific question:

“Given the profound neutropenia and new fever, should we proceed with the institutional febrile neutropenia pathway while cultures are pending?”

Useful English Expressions

  • “The patient remains hemodynamically stable.”
  • “There is no evidence of active bleeding.”
  • “The absolute neutrophil count has declined.”
  • “The patient is currently on day eight of induction therapy.”
  • “The disease is in remission.”
  • “The disease has progressed despite treatment.”
  • “The leading concern is febrile neutropenia.”
  • “The cause of the cytopenias is likely multifactorial.”
  • “We are awaiting the final pathology results.”
  • “The next step depends on the molecular findings.”

Professional Conduct During An Observership

An observership is generally a shadowing experience without independent patient contact or clinical care. AMA guidance describes observerships as strictly observational experiences without hands-on patient contact.

During the experience:

  • Introduce yourself as an observer.
  • Follow institutional rules.
  • Do not examine or counsel patients without authorization.
  • Do not document in the medical record without formal permission.
  • Do not photograph screens, documents, or patients.
  • Do not record identifiable information.
  • Ask questions at appropriate times.
  • Confirm whether you may present a case for educational purposes.

Maintain A Learning Log

Without including identifiers, record:

  • One clinical pattern.
  • One English expression.
  • One diagnostic decision.
  • One communication strategy.
  • One observed complication.
  • One question for later study.

Conclusion

An effective hematology-oncology presentation should answer:

  1. What is the diagnosis and current disease status?
  2. Which phase of treatment is the patient in?
  3. What is the most urgent problem?
  4. Which findings support the assessment?
  5. What needs to happen next?

The best presentation is not the longest one. It is the presentation that turns a large amount of information into a clear clinical decision.

References

  1. National Cancer Institute. Tests and Procedures Used to Diagnose Cancer.
  2. National Cancer Institute. Acute Myeloid Leukemia Treatment.
  3. American Medical Association. Guidelines for Establishing an Observership for International Medical Graduates.
  4. American Medical Association. Finding an Observership: Frequently Asked Questions.

Learn more about our school

I want to know more